Challenges in Defining a Reference Set of Differentially Expressed lncRNAs in Ulcerative Colitis by Meta-Analysis DOI Creative Commons
Christopher G. Fenton,

Mithlesh Kumar Ray,

Ruth H. Paulssen

et al.

Current Issues in Molecular Biology, Journal Year: 2024, Volume and Issue: 46(4), P. 3164 - 3174

Published: April 5, 2024

The study aimed to identify common differentially expressed lncRNAs from manually curated ulcerative colitis (UC) gene expression omnibus (GEO) datasets. Nine UC transcriptomic datasets of clearly annotated human colonic biopsies were included in the study. select active samples and controls. R packages geneknitR, gprofiler, clusterProfiler used for symbol annotation. EdgeR package was analyze differential expression. This resulted a total nineteen that at least three nine GEO Several found associated with promoting colorectal cancer (CRC) through regulating expression, epithelial mesenchymal transition (EMT), cell cycle progression, by tumor proliferation, invasion, migration. several varied between disease states tissue locations within same state. identified may function as general markers independent biopsy location, age, gender, or treatment, thereby representing comparative resource future comparisons using available

Language: Английский

Nanotherapeutic approaches for delivery of long non-coding RNAs: an updated review with emphasis on cancer DOI
Fatemeh Davodabadi, Shekoufeh Mirinejad, Sumira Malik

et al.

Nanoscale, Journal Year: 2024, Volume and Issue: 16(8), P. 3881 - 3914

Published: Jan. 1, 2024

The long noncoding RNAs (lncRNAs) comprise a wide range of RNA species whose length exceeds 200 nucleotides, which regulate the expression genes and cellular functions in organisms.

Language: Английский

Citations

11

Connecting the Dots: LncRNAs in the KRAS Pathway and Cancer DOI
Mudasir Maqbool, Md Sadique Hussain, Ajay Singh Bisht

et al.

Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 262, P. 155570 - 155570

Published: Aug. 29, 2024

Language: Английский

Citations

10

lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer DOI Creative Commons
Asif Ahmad Bhat, Muhammad Afzal, Ehssan Moglad

et al.

Clinical and Experimental Medicine, Journal Year: 2024, Volume and Issue: 24(1)

Published: Sept. 26, 2024

Abstract Long non-coding RNAs (lncRNAs) have emerged as crucial regulators in various cellular processes, including cancer progression and stress response. Recent studies demonstrated that copper accumulation induces a unique form of cell death known cuproptosis, with lncRNAs playing key role regulating cuproptosis-associated pathways. These may trigger cell-specific responses to stress, presenting new opportunities prognostic markers therapeutic targets. This paper delves into the cuproptosis-mediated cancer, underscoring their potential biomarkers targets for innovative strategies. A thorough review scientific literature was conducted, utilizing databases such PubMed, Google Scholar, ScienceDirect, search terms like 'lncRNAs,' 'cuproptosis,' 'cancer.' Studies were selected based on relevance lncRNA regulation cuproptosis pathways implications prognosis treatment. The highlights significant contribution cuproptosis-related genes pathways, impacting metabolism, mitochondrial responses, apoptotic signaling. Specific are breast, lung, liver, ovarian, pancreatic, gastric cancers. objective this article is explore cancers mediated by cuproptosis.

Language: Английский

Citations

9

Delving Into lncRNA‐Mediated Regulation of Autophagy‐Associated Signaling Pathways in the Context of Breast Cancer DOI Open Access
Chou‐Yi Hsu, Saade Abdalkareem Jasim, Pooja Bansal

et al.

Cell Biology International, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 28, 2025

Breast cancer is a multifaceted and prevalent malignancy, impacting considerable proportion of women globally. Numerous signaling pathways intricately regulate cellular functions such as growth, proliferation, survival. Among the various regulators, lncRNAs have emerged significant players despite their inability to encode proteins. An expanding body literature underscores pivotal roles play in biology, particularly context breast cancer. Autophagy, process dedicated degradation recycling components, now recognized crucial factor initiation progression. The interplay between lncRNAs, pathways, autophagy pathophysiology remains an active area investigation. Researchers identified specific that are dysregulated patients, influencing modulation key pathways. Using experimental methodologies bioinformatics approaches, multiple been elucidated, providing deeper insights into contributions pathogenesis metastatic processes. In summary, pathophysiological landscape characterized by complex interactions involving lncRNA-mediated autophagy. This understanding paves way for identifying novel therapeutic targets, prognostic markers, diagnostic ultimately contributing improved treatment outcomes management.

Language: Английский

Citations

1

Long Noncoding RNA VLDLR-AS1 Levels in Serum Correlate with Combat-Related Chronic Mild Traumatic Brain Injury and Depression Symptoms in US Veterans DOI Open Access
Rekha Patel, Meredith Krause‐Hauch, Kimbra Kenney

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(3), P. 1473 - 1473

Published: Jan. 25, 2024

More than 75% of traumatic brain injuries (TBIs) are mild (mTBI) and military service members often experience repeated combat-related mTBI. The chronic comorbidities concomitant with repetitive mTBI (rmTBI) include depression, post-traumatic stress disorder or neurological dysfunction. This study sought to determine a long noncoding RNA (lncRNA) expression signature in serum samples that correlated rmTBI years after the incidences. Serum were obtained from Long-Term Impact Military-Relevant Brain-Injury Consortium Chronic Effects Neurotrauma (LIMBIC CENC) repository, participants unexposed TBI who had rmTBI. Four lncRNAs identified as consistently present all samples, detected via droplet digital PCR packaged exosomes enriched for CNS origin. results, using qPCR, demonstrated lncRNA VLDLR-AS1 levels significantly lower among individuals compared those no lifetime TBI. ROC analysis determined an AUC 0.74 (95% CI: 0.6124 0.8741; p = 0.0012). optimal cutoff was ≤153.8 ng. A secondary clinical data LIMBIC CENC conducted evaluate psychological symptom burden, results show MALAT1 symptoms depression. In conclusion, may serve blood biomarker identifying depression patients.

Language: Английский

Citations

6

LncRNA SERPINB9P1 Mitigates Cerebral Injury Induced by Oxygen‒Glucose Deprivation/Reoxygenation by Interacting with HSPA2 DOI
Miao Lv, Xiaoxiao Song, Weitao Wang

et al.

Molecular Neurobiology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 11, 2025

Language: Английский

Citations

0

LncRNADANCR Promotes ESCC Progression and Function as ceRNA to Regulate DDIT3 Expression by Sponging microRNA‐3193 DOI Creative Commons
Heng Xiao, Tong Zhou, Yanfang Yang

et al.

Cancer Science, Journal Year: 2025, Volume and Issue: unknown

Published: March 12, 2025

ABSTRACT Long non‐coding RNAs (lncRNAs) have emerged as crucial regulators of cancer development and progression. Among them, Differentiation Antagonizing Non‐Protein Coding RNA (DANCR) has been implicated in various malignancies, including esophageal squamous cell carcinoma (ESCC). This study explores the clinical characteristics, prognostic implications, functional roles, molecular mechanisms DANCR ESCC. Our results demonstrate that is highly expressed ESCC, acts an oncogene ESCC both vitro vivo. Through bioinformatics analysis experimental validation, we revealed promotes progression by sponging miR‐3193 regulating its target gene DDIT3 expression. These findings highlight critical role suggest potential a predictor drug therapeutic target.

Language: Английский

Citations

0

Latest Update on lncRNA in Epithelial Ovarian Cancer—A Scoping Review DOI Creative Commons
Katarzyna Kwas, Maria Szubert, Jacek R. Wilczyński

et al.

Cells, Journal Year: 2025, Volume and Issue: 14(7), P. 555 - 555

Published: April 7, 2025

Long noncoding RNAs (lncRNAs) are RNA molecules exceeding 200 nucleotides that do not encode proteins yet play critical roles in regulating gene expression at multiple levels, such as chromatin modification and transcription. These significantly engaged cancer progression, development, metastasis, chemoresistance. However, the function of lncRNAs epithelial ovarian (EOC) has been thoroughly studied. EOC remains challenging due to its complex molecular pathogenesis, characterized by genetic epigenetic alterations. Emerging evidence suggests lncRNAs, XIST, H19, NEAT1, MALAT1, involved modulating signaling pathways, influencing processes like cell proliferation, invasion, migration, Despite extensive research, precise mechanism acting pathogenesis treatment resistance still needs be fully understood, highlighting need for further studies. This review aims provide an updated overview current understanding EOC, emphasizing their potential biomarkers therapeutic targets. We point out gaps knowledge regarding lncRNAs’ influence on (EOC), deliberating new possible research areas.

Language: Английский

Citations

0

Biomarkers for the detection of circulating tumor cells DOI
Karol Gostomczyk,

Magdalena Drozd,

Mohammed Dheyaa Marsool Marsool

et al.

Experimental Cell Research, Journal Year: 2025, Volume and Issue: 448(1), P. 114555 - 114555

Published: April 12, 2025

Language: Английский

Citations

0

Diagnostic, Prognostic, and Predictive Short and Long Non-coding RNA Biomarkers in Cancer DOI

Nithya Kruthi,

Janvi Bhatankar,

Ramgopal Dhakar

et al.

Published: Jan. 1, 2025

Language: Английский

Citations

0